Research & KnowledgeEvent: September 3, 2026
TNO expanded the characterization of its multifactorial CKM mouse model and demonstrated distinct cardiac transcriptomic changes associated with disease progression.
Published
Signal category
Research & Knowledge
Quote
“we further expanded the cardiac characterization of our CKM model and demonstrated: - Distinct cardiac transcriptomic changes associated with disease progression”
— Robert Ostendorf|TNO team
Company
TNO
Wij zijn de onafhankelijke innovatie, onderzoeks- en adviesorganisatie voor bedrijven en overheden. #ditisonzetijd
- Industry
- Research Services
- Location
- 2595 DA The Hague, NL
- Company size
- 5,850 employees
TNO is an independent organisation for applied research. We connect people and knowledge to create innovations that boost the competitive strength of industry and the well-being of society in a sustainable way. Our goal is to connect, change and accelerate: Innovation for life.
Founded 1932